Andere Kunden interessierten sich auch für
![Diagnosis of Peste des Petits Ruminants under limited resource setting]( "Diagnosis of Peste des Petits Ruminants under limited resource setting")
Diagnosis of Peste des Petits Ruminants under limited resource setting32,99 €![Épidémiologie moléculaire de Mycobacterium tuberculosis à Bamako, Mali]( "Épidémiologie moléculaire de Mycobacterium tuberculosis à Bamako, Mali")
Épidémiologie moléculaire de Mycobacterium tuberculosis à Bamako, Mali19,99 €![Animal Wastes: A Public Health Pathetic in Developing Countries]( "Animal Wastes: A Public Health Pathetic in Developing Countries")
Animal Wastes: A Public Health Pathetic in Developing Countries36,99 €![Antimicrobial Resistance in Developing Countries]( "Antimicrobial Resistance in Developing Countries")
Antimicrobial Resistance in Developing Countries110,99 €![Diagnosis of Mycobacterium tuberculosis: An Egyptian experience]( "Diagnosis of Mycobacterium tuberculosis: An Egyptian experience")
Diagnosis of Mycobacterium tuberculosis: An Egyptian experience46,99 €![Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions]( "Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions")
Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions190,99 €![Fungal Spores: Major Concern in Allergic Airway Diseases]( "Fungal Spores: Major Concern in Allergic Airway Diseases")
Fungal Spores: Major Concern in Allergic Airway Diseases32,99 €
Multidrug-Resistant Tuberculosis is a Major Public Health Problem Around the World, Despite Strategies (DOTS, DOTS PLUS and Stop TB) set up to fight this scourge, MDR-TB is still a real threat to Global Health Programs. The situation is particularly serious in developing countries, which account for nearly 95% of detected cases. The emergence of MDR-TB strains could jeopardize the success of TB eradication programs. Given the limitations of diagnostic and follow-up tests for patients undergoing treatment in resource-poor countries (DRC), we evaluated two tests: the bladder susceptibility test that detects resistance to rifampicin, Kanamycin and Ofloxacin and the Fluorescein diacetate staining technique, which makes it possible to reveal only viable bacilli. Slide susceptibility was able to determine within 10 days the level of rifampicin resistance (47.3%), Ofloxacin (15.7%) and Kanamycin (16.7%) in whole population.